EA

Elcemar Almeida

Director Director DIN 00583077
DIN 00583077 First appointment Mar 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2005
Shareholding value Locked Premium profile

About Elcemar Almeida

Data last updated:

Elcemar Almeida has 21 years in corporate governance. Formerly with 1 company, such as Strides Pharma Science Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00583077
Primary Designation Director
First Appointment 25 Mar 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Strides Pharma Science Limited L24230MH1990PLC057062
Director25 Mar 20051990Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Strides Pharma Science Limited
Premium access

Shareholding and investment profile for Elcemar Almeida

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elcemar Almeida

Elcemar Almeida has 21 years in corporate governance. Formerly with 1 company, such as Strides Pharma Science Limited. Engaged in General Business. Contributes to corporate operations.

Elcemar Almeida is associated with 0 companies as a director.

Elcemar Almeida has expertise in General Business.

Elcemar Almeida has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available